Urology Annals

ERRATUM
Year
: 2020  |  Volume : 12  |  Issue : 4  |  Page : 396-

Erratum: Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography


 

Correspondence Address:




How to cite this article:
. Erratum: Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography.Urol Ann 2020;12:396-396


How to cite this URL:
. Erratum: Evaluation of response in patients of metastatic castration resistant prostate cancer undergoing systemic radiotherapy with lutetium177-prostate-specific membrane antigen: A comparison between response evaluation criteria in solid tumors, positron-emission tomography response criteria in solid tumors, European organization for research and treatment of cancer, and MDA criteria assessed by gallium 68-prostate-specific membrane antigen positron-emission tomography-computed tomography. Urol Ann [serial online] 2020 [cited 2021 Jan 18 ];12:396-396
Available from: https://www.urologyannals.com/article.asp?issn=0974-7796;year=2020;volume=12;issue=4;spage=396;epage=396;aulast=;type=0